The European pharmaceutical regulator EMA will start next week with an investigation into the clinical trials in developing the Russian corona vaccine Sputnik V, the British newspaper Financial Times reported Wednesday.
The European Medicines Agency wants to know whether the trials have been conducted ethically and whether international clinical and scientific guidelines have been adhered to.
EMA’s announcement comes after sources well-fed into the regulator’s authorization process said the clinical trials for the Sputnik V vaccine were not ethically conducted.
Kirill Dimitriev, the head of Russia’s Direct Investment Fund, says no pressure was put on subjects.
According to the head of the state institution behind the development of Sputnik V, the development of the Russian corona vaccine meets all standards, according to the head of state institution.